Answers are grounded in this paper and cite their sources.
ArticlePlus Click on the links below to access all the ArticlePlus for this article. Please note that ArticlePlus files may launch a viewer application outside of your web browser. https://links.lww.com/QAD/A7 Haematopoiesis is supported by a complex network of cell types, including non-haematopoietic (fibroblasts, adypocytes and endothelial cells) and haematopoietic cells [1]. Haematopoietic cells proliferate and differentiate in the interstices of this network, being in close contact with long cytoplasmic processes of stromal cells [2]. One major function of stromal cells is the production of IL-7 [3], which acts as a master regulator of T cell homeostasis, expanding naive and peripheral T cell populations [4,5]. In HIV-1-infected individuals, an inverse correlation has been observed between the levels of circulating IL-7 and the peripheral CD4 T cells [6], as the production of other cytokines diminishes [7]. It may be hypothesized that in advanced HIV-1 disease, stromal cells produce higher levels of IL-7 as a compensatory mechanism to the decline in the CD4 T cell count. At present, no data are available regarding either IL-7 production by bone marrow stromal cells in HIV-1-infected patients and the effects exerted by antiretroviral therapy on this cytokine. In this study we analysed stromal IL-7 production in bone marrow cultures before and during highly active antiretroviral therapy (HAART) in a group of HIV-1-infected patients. Bone marrow mononuclear cells were collected from a breastbone aspirate in six HIV-1-infected patients, naive for HAART, with CD4 T cell counts between 100 and 300 cells/μl and plasma HIV-1 viral loads greater than 10 000 copies/ml. A second bone marrow evaluation was performed after 3 months of HAART. Three seronegative individuals were studied as controls. All subjects, who underwent bone marrow aspirates for peripheral blood haematological abnormalities, gave their written informed consent for the breastbone aspiration, according to the Ethical Committee procedures at our Institute. Bone marrow mononuclear cells were cultured in 24-well plates in Iscove's modified Dulbecco's medium (Gibco BRL, Life Technology Italia srl, Milan, Italy), supplemented with 10% fetal calf serum, 10% horse serum, 100 IU/ml penicillin–streptomycin and 100 IU/ml glutamine, until stromal confluence (3–4 weeks). Supernatants were collected after 24 h of culture and measurements of IL-7 were performed using enzyme-linked immunosorbent assay with an ultrasensitive kit (R&D System, Minneapolis, MN, USA). Non-parametric statistics were used (Wilcoxon test) for comparisons between the parameters analysed before and during therapy. Compared with seronegative subjects, stromal cells from HIV-1-infected individuals spontaneously produced higher levels of IL-7 before starting HAART (0.17 ± 0.10 versus 0.32 ± 0.12 pg/ml, respectively). In Fig. 1 IL-7 production is depicted for each patient before and during therapy. The levels of stromal IL-7 production significantly decreased in all patients during therapy, reaching values comparable to those observed in control subjects (0.19 ± 0.06 pg/ml, P = 0.02 versus baseline). This finding was associated with a significantly increased number of CD4 T cells (mean values from 188 ± 81 to 288 ± 54 cells/μl after 3 months of therapy, P = 0.04) and a significant decrease in HIV-1-RNA plasma levels (from 5 ± 0.6 to 1.4 ± 0.8 log10/ml, P = 0.02).Fig. 1.: IL-7 levels in supernatants of stromal cell cultures from HIV-1-infected patients before and during highly active antiretroviral therapy. □ Before highly active antiretroviral therapy (HAART); ▪ during HAART.Furthermore, an inverse relationship has been observed between bone marrow stromal IL-7 production and peripheral CD4 T cell counts (r = −0.767; P = 0.003). IL-7 is well recognized as a crucial cytokine for the early development of T and B lymphocyte subpopulations. Thymic epithelial cells and bone marrow stromal cells are the primary sources of circulating IL-7 [8]. In this study we have shown that the decreased CD4 T cell count is associated with increased stromal IL-7 production. During HAART, the control of viral replication and the recovery of CD4 T cell numbers reverse bone marrow stromal IL-7 production, which reaches values comparable with those observed in control subjects. This contrasts with our observation that other cytokines (IL-2, IFN-γ, IL-4, IL-10) increase after immunological reconstitution during HAART [9]. The mechanisms responsible for the feedback between bone marrow stromal cells and T cells remain unknown. It may be hypothesized that constitutively produced soluble factors by T cells may control the stromal cell production of IL-7 [8]. The depletion of T cells in the bone marrow, with the decreased production of such soluble factors, would lead to increased levels of IL-7, and vice versa. A possible candidate that exerts this action is transforming growth factor beta, which is known to be produced by T cells and to regulate the production of IL-7 by bone marrow stroma [10].
No takes yet. Share an insight, caveat, or question.
Isgrò et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: